[
  {
    "ts": "2025-10-10T23:07:07+00:00",
    "headline": "Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today",
    "summary": "The company could soon be swallowed by a very large peer -- which also happens to be a business partner.",
    "url": "https://www.fool.com/investing/2025/10/10/why-protagonist-therapeutics-stock-skyrocketed-by/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c61316c6-530b-3af3-9ef3-855d8d7f23fc",
      "content": {
        "id": "c61316c6-530b-3af3-9ef3-855d8d7f23fc",
        "contentType": "STORY",
        "title": "Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today",
        "description": "",
        "summary": "The company could soon be swallowed by a very large peer -- which also happens to be a business partner.",
        "pubDate": "2025-10-10T23:07:07Z",
        "displayTime": "2025-10-10T23:07:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c0a35ede4949c1499fb902fede3bf1a4",
          "originalWidth": 1400,
          "originalHeight": 787,
          "caption": "Two people in white lab coats looking at a computer display.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tddkYt.9TgpO8jU.8t16yQ--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c0a35ede4949c1499fb902fede3bf1a4.cf.webp",
              "width": 1400,
              "height": 787,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oa1Fbig5LfVtOx47xdKlTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c0a35ede4949c1499fb902fede3bf1a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/10/why-protagonist-therapeutics-stock-skyrocketed-by/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-protagonist-therapeutics-stock-skyrocketed-230707523.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T22:16:00+00:00",
    "headline": "Q3 Earnings Season Setup Remains Favorable: What to Know",
    "summary": "The big banks dominate this week's reporting docket, but we also have several bellwethers from other sectors reporting, including Johnson & Johnson, United Air Lines, and others.",
    "url": "https://finance.yahoo.com/news/q3-earnings-season-setup-remains-221600369.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "970e9d19-1b73-38d6-8f96-90a6122cf9bd",
      "content": {
        "id": "970e9d19-1b73-38d6-8f96-90a6122cf9bd",
        "contentType": "STORY",
        "title": "Q3 Earnings Season Setup Remains Favorable: What to Know",
        "description": "",
        "summary": "The big banks dominate this week's reporting docket, but we also have several bellwethers from other sectors reporting, including Johnson & Johnson, United Air Lines, and others.",
        "pubDate": "2025-10-10T22:16:00Z",
        "displayTime": "2025-10-10T22:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5ffeb83ada09c44e2b9fdba5353a4fa9",
          "originalWidth": 620,
          "originalHeight": 360,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xmXaEuTbvyukFNvzZDWAXA--~B/aD0zNjA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ffeb83ada09c44e2b9fdba5353a4fa9.cf.webp",
              "width": 620,
              "height": 360,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZtkO4mz9o0k2zyiWipFMwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ffeb83ada09c44e2b9fdba5353a4fa9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/q3-earnings-season-setup-remains-221600369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/q3-earnings-season-setup-remains-221600369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "CSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T20:20:00+00:00",
    "headline": "Johnson & Johnson recommends shareholders reject \"mini-tender\" offer by Tutanota",
    "summary": "NEW BRUNSWICK, N.J., October 10, 2025--Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & Johnson common stock at a price of $145.00 per share in cash. Tutanota’s offer price of $145.00 per share was well below the closing price of Johnson & Johnson common stock on September 26, 2025, the last",
    "url": "https://finance.yahoo.com/news/johnson-johnson-recommends-shareholders-reject-202000484.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3be3f805-aa38-394d-98da-76efe1838afd",
      "content": {
        "id": "3be3f805-aa38-394d-98da-76efe1838afd",
        "contentType": "STORY",
        "title": "Johnson & Johnson recommends shareholders reject \"mini-tender\" offer by Tutanota",
        "description": "",
        "summary": "NEW BRUNSWICK, N.J., October 10, 2025--Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & Johnson common stock at a price of $145.00 per share in cash. Tutanota’s offer price of $145.00 per share was well below the closing price of Johnson & Johnson common stock on September 26, 2025, the last",
        "pubDate": "2025-10-10T20:20:00Z",
        "displayTime": "2025-10-10T20:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/43e096d52d19738c37dd35e8558e82e9",
          "originalWidth": 2404,
          "originalHeight": 224,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/orQabfWeH9qu3v_aKYtM4g--~B/aD0yMjQ7dz0yNDA0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/43e096d52d19738c37dd35e8558e82e9.cf.webp",
              "width": 2404,
              "height": 224,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G6a30puWrA0egQGUvYwAjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/43e096d52d19738c37dd35e8558e82e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-recommends-shareholders-reject-202000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-recommends-shareholders-reject-202000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T19:53:23+00:00",
    "headline": "Protagonist Stock Surges on Johnson & Johnson Report",
    "summary": "Protagonist Therapeutics shares soared 30% Friday after The Wall Street Journal reported that the biopharma company was in talks with Johnson & Johnson about a possible acquistion. See more of the exclusive ...",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-10-2025/card/protagonist-stock-surges-on-johnson-johnson-report-yO0SCotlMyLnNDeHyMUy?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "3193a42e-2904-3369-82d7-9be1ff9af960",
      "content": {
        "id": "3193a42e-2904-3369-82d7-9be1ff9af960",
        "contentType": "STORY",
        "title": "Protagonist Stock Surges on Johnson & Johnson Report",
        "description": "",
        "summary": "Protagonist Therapeutics shares soared 30% Friday after The Wall Street Journal reported that the biopharma company was in talks with Johnson & Johnson about a possible acquistion. See more of the exclusive ...",
        "pubDate": "2025-10-10T19:53:23Z",
        "displayTime": "2025-10-10T19:53:23Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3193a42e-2904-3369-82d7-9be1ff9af960/protagonist-stock-surges-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-10-2025/card/protagonist-stock-surges-on-johnson-johnson-report-yO0SCotlMyLnNDeHyMUy?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PTGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T19:38:10+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Late Afternoon",
    "summary": "Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "477b3b96-6b85-3256-abef-fd665d28c064",
      "content": {
        "id": "477b3b96-6b85-3256-abef-fd665d28c064",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Late Afternoon",
        "description": "",
        "summary": "Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t",
        "pubDate": "2025-10-10T19:38:10Z",
        "displayTime": "2025-10-10T19:38:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-193810858.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "PTGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T18:21:15+00:00",
    "headline": "Trump's China tariff threat sinks stocks, Applied Digital surges",
    "summary": "Yahoo Finance Anchor Josh Lipton reports on three stories Wall Street is watching in the latest Market Minute: US stocks tumble as US-China trade tensions intensify, Protagonist Therapeutic (PTGX) shares surge on WSJ reports of acquisition talks with Johnson & Johnson (JNJ), and Applied Digital (APLD) stock is climbing after posting its fiscal Q1 earnings report. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finance.yahoo.com/video/trumps-china-tariff-threat-sinks-182115264.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "d327f3dd-ef71-38aa-9e3d-ed38c436cf55",
      "content": {
        "id": "d327f3dd-ef71-38aa-9e3d-ed38c436cf55",
        "contentType": "VIDEO",
        "title": "Trump's China tariff threat sinks stocks, Applied Digital surges",
        "description": "<p>Yahoo Finance Anchor <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/josh-lipton/\">Josh Lipton</a> reports on three stories Wall Street is watching in the latest <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-minute/\">Market Minute</a>: US stocks tumble as US-China trade tensions intensify, Protagonist Therapeutic (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/PTGX\">PTGX</a>) shares surge on <a data-i13n=\"cpos:4;pos:1\" href=\"https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d?gaa_at=eafs&gaa_n=ASWzDAj3TkQGQ0SYNfksXlNsWHi9DHC1fDT1VtJyePYLpD08ETt-HErbColdzPoN4Zc%3D&gaa_ts=68e94f42&gaa_sig=8xUyn_zSd3I_loJ49pvstk-2tQfDMbK12tP0GafBrOyt_6Ib1YoYc0eaW2mfv7NvdlmPxPUF7STHCiLR0gZ7Ng%3D%3D\">WSJ reports</a> of acquisition talks with Johnson & Johnson (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/JNJ\">JNJ</a>), and Applied Digital (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/APLD\">APLD</a>) stock is climbing after posting its fiscal Q1 earnings report.</p>\n<p>Stay up to date on the latest market action, minute-by-minute, with <a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-minute/\">Yahoo Finance's Market Minute.</a></p>",
        "summary": "Yahoo Finance Anchor Josh Lipton reports on three stories Wall Street is watching in the latest Market Minute: US stocks tumble as US-China trade tensions intensify, Protagonist Therapeutic (PTGX) shares surge on WSJ reports of acquisition talks with Johnson & Johnson (JNJ), and Applied Digital (APLD) stock is climbing after posting its fiscal Q1 earnings report. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
        "pubDate": "2025-10-10T18:21:15Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/d5bc7370-a605-11f0-9f4b-565eb2b57070",
          "originalWidth": 5035,
          "originalHeight": 2834,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZbJircRYdbiHkc08WUqx1A--~B/aD0yODM0O3c9NTAzNTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/d5bc7370-a605-11f0-9f4b-565eb2b57070.cf.webp",
              "width": 5035,
              "height": 2834,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E.rmud5M9Eje0dTvwwnHmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/d5bc7370-a605-11f0-9f4b-565eb2b57070.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/trumps-china-tariff-threat-sinks-182115264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/trumps-china-tariff-threat-sinks-182115264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "APLD"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T18:07:36+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Friday Afternoon",
    "summary": "Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "a7561ee0-e53d-3718-94c5-04fe3bd8b0dd",
      "content": {
        "id": "a7561ee0-e53d-3718-94c5-04fe3bd8b0dd",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Friday Afternoon",
        "description": "",
        "summary": "Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care",
        "pubDate": "2025-10-10T18:07:36Z",
        "displayTime": "2025-10-10T18:07:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-180736952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "USNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T17:27:01+00:00",
    "headline": "Top Midday Gainers",
    "summary": "Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F",
    "url": "https://finance.yahoo.com/news/top-midday-gainers-172701089.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f55d9747-fbb3-33d7-b0b2-e480d15863b3",
      "content": {
        "id": "f55d9747-fbb3-33d7-b0b2-e480d15863b3",
        "contentType": "STORY",
        "title": "Top Midday Gainers",
        "description": "",
        "summary": "Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F",
        "pubDate": "2025-10-10T17:27:01Z",
        "displayTime": "2025-10-10T17:27:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-gainers-172701089.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-gainers-172701089.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QNRX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GWH"
            },
            {
              "symbol": "PTGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T16:19:00+00:00",
    "headline": "Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.",
    "summary": "The recent cavalcade of biotech deals continued Friday morning, when  Bristol Myers Squibb  said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech designing RNA-based medicines.  Its lead program, a potential treatment for autoimmune conditions called OTX-201, isn’t expected to enter human trials until next year.  The Orbital deal is Bristol’s largest since February 2024, when it closed a $4.1 billion acquisition of RayzeBio, a cancer-focused biotech.",
    "url": "https://www.barrons.com/articles/bristol-myers-squibb-orbital-therapeutics-9cbc5536?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9d415ae-bc30-3141-a6cb-2286f58343a3",
      "content": {
        "id": "e9d415ae-bc30-3141-a6cb-2286f58343a3",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.",
        "description": "",
        "summary": "The recent cavalcade of biotech deals continued Friday morning, when  Bristol Myers Squibb  said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech designing RNA-based medicines.  Its lead program, a potential treatment for autoimmune conditions called OTX-201, isn’t expected to enter human trials until next year.  The Orbital deal is Bristol’s largest since February 2024, when it closed a $4.1 billion acquisition of RayzeBio, a cancer-focused biotech.",
        "pubDate": "2025-10-10T16:19:00Z",
        "displayTime": "2025-10-10T16:19:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e9d415ae-bc30-3141-a6cb-2286f58343a3/bristol-myers-squibb-buys.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bf402q.1QSge2in2qsVa4w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9_PIBaIStwamvAA7QXT2sQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f8bbf75eff3be3b648bed5cb28cacca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/bristol-myers-squibb-orbital-therapeutics-9cbc5536?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "AKRO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T16:10:00+00:00",
    "headline": "Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know",
    "summary": "J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.",
    "url": "https://finance.yahoo.com/news/buying-j-j-stock-ahead-161000544.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "db636c05-ab6a-3a2f-850e-00c531551b2e",
      "content": {
        "id": "db636c05-ab6a-3a2f-850e-00c531551b2e",
        "contentType": "STORY",
        "title": "Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know",
        "description": "",
        "summary": "J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.",
        "pubDate": "2025-10-10T16:10:00Z",
        "displayTime": "2025-10-10T16:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buying-j-j-stock-ahead-161000544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buying-j-j-stock-ahead-161000544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "TEVA"
            },
            {
              "symbol": "TEVJF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:53:51+00:00",
    "headline": "Top Midday Stories: Trump Threatens 'Massive' Tariff Raise on China; Nvidia Chips Face Higher Scrutiny at China Customs",
    "summary": "All three major US stock indexes were in the red around midday trading Friday, with the Nasdaq Compo",
    "url": "https://finance.yahoo.com/news/top-midday-stories-trump-threatens-155351986.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "e2b33a45-6a75-3ece-b6d5-e9aca80b5196",
      "content": {
        "id": "e2b33a45-6a75-3ece-b6d5-e9aca80b5196",
        "contentType": "STORY",
        "title": "Top Midday Stories: Trump Threatens 'Massive' Tariff Raise on China; Nvidia Chips Face Higher Scrutiny at China Customs",
        "description": "",
        "summary": "All three major US stock indexes were in the red around midday trading Friday, with the Nasdaq Compo",
        "pubDate": "2025-10-10T15:53:51Z",
        "displayTime": "2025-10-10T15:53:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-trump-threatens-155351986.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-trump-threatens-155351986.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "APLD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:53:23+00:00",
    "headline": "Protagonist Therapeutics stock surges after J&J acquisition talks report",
    "summary": "Investing.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ) is in talks to acquire the biotech company.",
    "url": "https://finance.yahoo.com/news/protagonist-therapeutics-stock-surges-j-155323160.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "58f09ac7-b3f6-3576-a55b-a1b37ce7210f",
      "content": {
        "id": "58f09ac7-b3f6-3576-a55b-a1b37ce7210f",
        "contentType": "STORY",
        "title": "Protagonist Therapeutics stock surges after J&J acquisition talks report",
        "description": "",
        "summary": "Investing.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ) is in talks to acquire the biotech company.",
        "pubDate": "2025-10-10T15:53:23Z",
        "displayTime": "2025-10-10T15:53:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/protagonist-therapeutics-stock-surges-j-155323160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/protagonist-therapeutics-stock-surges-j-155323160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:13:00+00:00",
    "headline": "Johnson & Johnson in Talks to Buy Protagonist Therapeutics",
    "summary": "Johnson & Johnson  is in talks to buy  Protagonist Therapeutics  in a deal that would solidify the companies’ existing partnership, according to people familiar with the matter.  A deal is not guaranteed and the exact details being discussed couldn’t be learned, the people said.  Protagonist had a market value of over $4 billion as of Thursday’s close.",
    "url": "https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "6ca4dc00-7447-3fca-8eff-6bde82ec3062",
      "content": {
        "id": "6ca4dc00-7447-3fca-8eff-6bde82ec3062",
        "contentType": "STORY",
        "title": "Johnson & Johnson in Talks to Buy Protagonist Therapeutics",
        "description": "",
        "summary": "Johnson & Johnson  is in talks to buy  Protagonist Therapeutics  in a deal that would solidify the companies’ existing partnership, according to people familiar with the matter.  A deal is not guaranteed and the exact details being discussed couldn’t be learned, the people said.  Protagonist had a market value of over $4 billion as of Thursday’s close.",
        "pubDate": "2025-10-10T15:13:00Z",
        "displayTime": "2025-10-10T15:13:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6ca4dc00-7447-3fca-8eff-6bde82ec3062/johnson-johnson-in-talks-to.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/689d736afb17d40b89e3767d7c3b1724",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S4EFDf7atgMTgbeGZkCTYA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/689d736afb17d40b89e3767d7c3b1724.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ti1vMPUg8.3SRS.SAQWWcw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/689d736afb17d40b89e3767d7c3b1724.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "TKPHF"
            },
            {
              "symbol": "4502.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:06:00+00:00",
    "headline": "Big Banks Gear Up to Report Q3 Earnings",
    "summary": "Big Banks Gear Up to Report Q3 Earnings",
    "url": "https://finance.yahoo.com/news/big-banks-gear-report-q3-150600715.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e6fc7472-b1ad-3157-bbeb-6e8e3df33f61",
      "content": {
        "id": "e6fc7472-b1ad-3157-bbeb-6e8e3df33f61",
        "contentType": "STORY",
        "title": "Big Banks Gear Up to Report Q3 Earnings",
        "description": "",
        "summary": "Big Banks Gear Up to Report Q3 Earnings",
        "pubDate": "2025-10-10T15:06:00Z",
        "displayTime": "2025-10-10T15:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/fcbe2006ed596c11475d4d73efcc61dc",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MrobNeR420E6uNRjI2dQWg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fcbe2006ed596c11475d4d73efcc61dc.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_73k5B9fFj50_S6feSN3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fcbe2006ed596c11475d4d73efcc61dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/big-banks-gear-report-q3-150600715.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/big-banks-gear-report-q3-150600715.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "WFC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "DPZ"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T14:32:00+00:00",
    "headline": "Pre-markets Up Slightly to Start Friday Trading",
    "summary": "We're devoid of major market catalysts until Q3 earnings season builds next week, when the Big Banks begin reporting on Tuesday morning.",
    "url": "https://finance.yahoo.com/news/pre-markets-slightly-start-friday-143200325.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "055f9315-bec8-3df7-b81e-ed6c1e73fee7",
      "content": {
        "id": "055f9315-bec8-3df7-b81e-ed6c1e73fee7",
        "contentType": "STORY",
        "title": "Pre-markets Up Slightly to Start Friday Trading",
        "description": "",
        "summary": "We're devoid of major market catalysts until Q3 earnings season builds next week, when the Big Banks begin reporting on Tuesday morning.",
        "pubDate": "2025-10-10T14:32:00Z",
        "displayTime": "2025-10-10T14:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-slightly-start-friday-143200325.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-slightly-start-friday-143200325.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "WFC"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T11:30:00+00:00",
    "headline": "Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress",
    "summary": "Johnson & Johnson (NYSE: JNJ) announced today that 17 abstracts featuring new clinical and real-world data will be presented at the annual European College of Neuropsychopharmacology (ECNP) Congress, taking place October 11-14 in Amsterdam, The Netherlands. Presentations include the latest research from across the Company's neuropsychiatry portfolio, including major depressive disorder (MDD), treatment-resistant depression (TRD), and schizophrenia.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-highlight-breadth-major-113000423.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "71d92ac2-ee8e-3a1a-87ab-fdaaeaf5edf9",
      "content": {
        "id": "71d92ac2-ee8e-3a1a-87ab-fdaaeaf5edf9",
        "contentType": "STORY",
        "title": "Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress",
        "description": "",
        "summary": "Johnson & Johnson (NYSE: JNJ) announced today that 17 abstracts featuring new clinical and real-world data will be presented at the annual European College of Neuropsychopharmacology (ECNP) Congress, taking place October 11-14 in Amsterdam, The Netherlands. Presentations include the latest research from across the Company's neuropsychiatry portfolio, including major depressive disorder (MDD), treatment-resistant depression (TRD), and schizophrenia.",
        "pubDate": "2025-10-10T11:30:00Z",
        "displayTime": "2025-10-10T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/7666cc68e9666a174bca3f07e3f94721",
          "originalWidth": 400,
          "originalHeight": 38,
          "caption": "Johnson & Johnson (PRNewsfoto/Johnson & Johnson)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GXCxbsFDDz3fFTI03HwuBw--~B/aD0zODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/7666cc68e9666a174bca3f07e3f94721.cf.webp",
              "width": 400,
              "height": 38,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qhQKh0p3toIAfsx9SijYTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7666cc68e9666a174bca3f07e3f94721.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-highlight-breadth-major-113000423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-highlight-breadth-major-113000423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]